Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -190,600 | -159,300 | -274,100 | 9,000 | -760,500 |
| Depreciation Amortization | 116,200 | 88,000 | 68,300 | 34,800 | 364,600 |
| Income taxes - deferred | -5,500 | -5,100 | -12,400 | -12,200 | -8,900 |
| Accounts receivable | -24,400 | 52,700 | -29,600 | -50,000 | -21,600 |
| Accounts payable and accrued liabilities | -33,000 | -22,800 | 200 | -2,400 | 10,600 |
| Other Working Capital | 85,100 | 171,500 | 106,500 | -98,700 | -75,100 |
| Other Operating Activity | 110,900 | 13,600 | 126,000 | 56,900 | 284,600 |
| Operating Cash Flow | $58,700 | $138,600 | $-15,100 | $-62,600 | $-206,300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15,000 | -13,600 | -15,400 | -10,800 | -51,600 |
| Net Acquisitions | 110,200 | 110,200 | N/A | N/A | 270,200 |
| Other Investing Activity | 30,000 | 0 | 0 | 0 | -6,300 |
| Investing Cash Flow | $125,200 | $96,600 | $-15,400 | $-10,800 | $212,300 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 284,000 | 284,000 | 65,000 | 50,000 | 20,000 |
| Debt Repayment | -482,400 | -482,400 | -69,400 | -8,900 | -563,400 |
| Common Stock Issued | 22,700 | 22,700 | N/A | N/A | N/A |
| Other Financing Activity | -14,300 | -14,800 | -5,800 | -400 | 7,700 |
| Financing Cash Flow | $-190,000 | $-190,500 | $-10,200 | $40,700 | $-535,700 |
| Exchange Rate Effect | N/A | N/A | 0 | N/A | -1,200 |
| Beginning Cash Position | 111,700 | 111,700 | 111,700 | 111,700 | 642,600 |
| End Cash Position | 105,600 | 156,400 | 71,000 | 79,000 | 111,700 |
| Net Cash Flow | $-6,100 | $44,700 | $-40,700 | $-32,700 | $-530,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | 58,700 | 138,600 | -15,100 | -62,600 | -206,300 |
| Capital Expenditure | -22,900 | -21,200 | -15,400 | -10,800 | -51,600 |
| Free Cash Flow | 35,800 | 117,400 | -30,500 | -73,400 | -257,900 |